Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

A Survey of Home Dialysis Competency, Exposure & Barriers Among Nephrology Fellows in the United States

El Shamy O, Sparks MA, Shah AD, Bermudez M, Salani M, Abra G, Stern L, Collins A, Aggarwal V, Rivara MB, Shen JI, Berns JS.[...]

Recurrent Hyponatremia With Central Endocrine Dysfunction: A Diagnostic Challenge

Li R, Sidhu H, Han JY. Recurrent Hyponatremia With Central Endocrine Dysfunction: A Diagnostic Challenge. Cureus. 2026 Feb 23;18(2):e104126. doi: 10.7759/cureus.104126. PMID: 41890465; PMCID: PMC13016432.

Kidney Disease among the Compacts of Free Association Pacific Islander Community: A Hidden Crisis

Rhee CM, Palafox NA, Hayashida G. Kidney Disease among the Compacts of Free Association Pacific Islander Community: A Hidden Crisis. Clin J Am Soc Nephrol.[...]